Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1825392-15-1 | MDL No. : | MFCD28125547 |
Formula : | C25H35Cl2N3O4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RCCYSOYYXOWCJC-UHFFFAOYSA-N |
M.W : | 544.53 | Pubchem ID : | 76764700 |
Synonyms : |
|
Num. heavy atoms : | 35 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.48 |
Num. rotatable bonds : | 12 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 155.13 |
TPSA : | 92.06 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -7.17 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.45 |
Log Po/w (WLOGP) : | 3.35 |
Log Po/w (MLOGP) : | 2.58 |
Log Po/w (SILICOS-IT) : | 4.25 |
Consensus Log Po/w : | 2.73 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 1.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.85 |
Solubility : | 0.00767 mg/ml ; 0.0000141 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.06 |
Solubility : | 0.00469 mg/ml ; 0.00000862 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -6.85 |
Solubility : | 0.0000771 mg/ml ; 0.000000142 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 4.62 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 101078-51-7 ]
6-Methoxy-2-(p-tolyl)benzo[d]thiazole
Similarity: 0.60
[ 1841081-72-8 ]
1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride
Similarity: 0.55
[ 10205-71-7 ]
4-(6-Methoxybenzo[d]thiazol-2-yl)-N,N-dimethylaniline
Similarity: 0.55
[ 927871-76-9 ]
7-Methoxy-4-methyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine
Similarity: 0.54
[ 508186-14-9 ]
1-(2,3-Di(thiophen-2-yl)quinoxalin-6-yl)-3-(2-methoxyethyl)urea
Similarity: 0.54
[ 566169-93-5 ]
2-(4-(Methylamino)phenyl)benzo[d]thiazol-6-ol
Similarity: 0.60
[ 103440-65-9 ]
(2-Methylbenzo[d]thiazol-6-yl)methanol
Similarity: 0.54
[ 533928-74-4 ]
2,6-Bis(1-methyl-1H-benzo[d]imidazol-2-yl)pyridin-4-ol
Similarity: 0.54
[ 3543-74-6 ]
Ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
Similarity: 0.52
[ 20034-02-0 ]
(6-Methyl-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.51
[ 5747-48-8 ]
11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine
Similarity: 0.90
[ 111974-74-4 ]
11-(1-Piperazinyl)-dibenzo[b,f][1,4]thiazepine dihydrochloride
Similarity: 0.90
[ 13745-86-3 ]
11-Chlorodibenzo[b,f][1,4]thiazepine
Similarity: 0.62
[ 16234-15-4 ]
4-(2-Chlorothieno[3,2-d]pyrimidin-4-yl)morpholine
Similarity: 0.59
[ 1977-07-7 ]
11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
Similarity: 0.58
[ 5747-48-8 ]
11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine
Similarity: 0.90
[ 111974-74-4 ]
11-(1-Piperazinyl)-dibenzo[b,f][1,4]thiazepine dihydrochloride
Similarity: 0.90
[ 1977-07-7 ]
11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
Similarity: 0.58
[ 5786-68-5 ]
2-(Piperazin-1-yl)quinoline maleate
Similarity: 0.55